Kernel Capital confirm Hibergene Diagnostics, a portfolio Company of the Bank of Ireland Kernel Capital Funds has been awarded €1M in European Union Funding for its ‘Hg nCoV19’ test. The Dublin-based medtech company is working on a rapid diagnostic test for Covid-19, which is expected to deliver results within 60 minutes. The test will determine within 30 minutes if it is the Covid-19 virus, however, a negative result requires a further 30 minutes to confirm.

A spin-out from the Royal Victoria Hospital in Belfast, HiberGene produce very rapid near patient molecular tests for various infectious diseases which allows healthcare professionals to diagnose infections on the spot for both patients and staff within an hour, rather than the typical 72 hours response available by sending a sample to a laboratory. 

Hibergene are working in conjunction with a team at Queen’s University Belfast (QUB) and a hospital in Genoa. Clinical trials in the Genoa hospital are imminent and Hibergene is hoping to get similar trials up and running in Irish hospitals quickly.

The European Commission said the project was the 18th programme it will support under its recent emergency call for research and innovation into the coronavirus that causes Covid-19.  

# # #

For further information please contact:

Dawn Walsh, Kernel Capital.

Tel:  +353 87 122 6807